Literature DB >> 32964640

α-Methylene-β-Lactone Scaffold for Developing Chemical Probes at the Two Ends of the Selectivity Spectrum.

Lei Wang1, Louis P Riel1, Bekim Bajrami2, Bin Deng3,4, Amy R Howell1, Xudong Yao1,5.   

Abstract

The utilities of an α-methylene-β-lactone (MeLac) moiety as a warhead composed of multiple electrophilic sites are reported. We demonstrate that a MeLac-alkyne not only reacts with diverse proteins as a broadly reactive measurement probe, but also recruits reduced endogenous glutathione (GSH) to assemble a selective chemical probe of GSH-β-lactone (GSH-Lac)-alkyne in live cells. Tandem mass spectrometry reveals that MeLac reacts with nucleophilic cysteine, serine, lysine, threonine, and tyrosine residues, through either Michael or acyl addition. A peptide-centric proteomics platform demonstrates that the proteomic selectivity profiles of orlistat and parthenolide, which have distinct reactivities, are measurable by MeLac-alkyne as a high-coverage probe. The GSH-Lac-alkyne selectively probes the glutathione S-transferase P responsible for multidrug resistance. The assembly of the GSH-Lac probe exemplifies a modular and scalable route to develop selective probes with different recognizing moieties.
© 2020 Wiley-VCH GmbH.

Entities:  

Keywords:  chemical proteomics; glutathione S-transferase; methylenelactone; orlistat; parthenolide

Mesh:

Substances:

Year:  2020        PMID: 32964640      PMCID: PMC8114233          DOI: 10.1002/cbic.202000605

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  36 in total

1.  How chemoproteomics can enable drug discovery and development.

Authors:  Raymond E Moellering; Benjamin F Cravatt
Journal:  Chem Biol       Date:  2012-01-27

Review 2.  Reactive-cysteine profiling for drug discovery.

Authors:  Aaron J Maurais; Eranthie Weerapana
Journal:  Curr Opin Chem Biol       Date:  2019-03-18       Impact factor: 8.822

3.  Broad-Spectrum Kinase Profiling in Live Cells with Lysine-Targeted Sulfonyl Fluoride Probes.

Authors:  Qian Zhao; Xiaohu Ouyang; Xiaobo Wan; Ketan S Gajiwala; John C Kath; Lyn H Jones; Alma L Burlingame; Jack Taunton
Journal:  J Am Chem Soc       Date:  2017-01-04       Impact factor: 15.419

Review 4.  The role of glutathione-S-transferase in anti-cancer drug resistance.

Authors:  Danyelle M Townsend; Kenneth D Tew
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

5.  Chemical proteomics with sulfonyl fluoride probes reveals selective labeling of functional tyrosines in glutathione transferases.

Authors:  Christian Gu; D Alexander Shannon; Tom Colby; Zheming Wang; Mohammed Shabab; Selva Kumari; Joji Grace Villamor; Christopher J McLaughlin; Eranthie Weerapana; Markus Kaiser; Benjamin F Cravatt; Renier A L van der Hoorn
Journal:  Chem Biol       Date:  2013-04-18

6.  Mechanism of glutathione transferase P1-1-catalyzed activation of the prodrug canfosfamide (TLK286, TELCYTA).

Authors:  Daniel F A R Dourado; Pedro Alexandrino Fernandes; Maria João Ramos; Bengt Mannervik
Journal:  Biochemistry       Date:  2013-10-28       Impact factor: 3.162

7.  Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs).

Authors:  Santo Previti; Roberta Ettari; Sandro Cosconati; Giorgio Amendola; Khawla Chouchene; Annika Wagner; Ute A Hellmich; Kathrin Ulrich; R Luise Krauth-Siegel; Peter R Wich; Ira Schmid; Tanja Schirmeister; Jiri Gut; Philip J Rosenthal; Silvana Grasso; Maria Zappalà
Journal:  J Med Chem       Date:  2017-08-11       Impact factor: 7.446

8.  Proteome-wide covalent ligand discovery in native biological systems.

Authors:  Keriann M Backus; Bruno E Correia; Kenneth M Lum; Stefano Forli; Benjamin D Horning; Gonzalo E González-Páez; Sandip Chatterjee; Bryan R Lanning; John R Teijaro; Arthur J Olson; Dennis W Wolan; Benjamin F Cravatt
Journal:  Nature       Date:  2016-06-15       Impact factor: 49.962

9.  Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug.

Authors:  Victoria J Findlay; Danyelle M Townsend; Joseph E Saavedra; Gregory S Buzard; Michael L Citro; Larry K Keefer; Xinhua Ji; Kenneth D Tew
Journal:  Mol Pharmacol       Date:  2004-05       Impact factor: 4.436

10.  A fragment-based method to discover irreversible covalent inhibitors of cysteine proteases.

Authors:  Stefan G Kathman; Ziyang Xu; Alexander V Statsyuk
Journal:  J Med Chem       Date:  2014-05-28       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.